Cost-effectiveness of radiofrequency ablation versus percutaneous ethanol injection for early hepatocellular carcinoma in a resource-poor setting: a randomized trial
Authors:
- Guilherme Cayres MariottiGMGuilherme Cayres Mariotti
- Guilherme Eduardo Gonçalves FelgaGFGuilherme Eduardo Gonçalves Felga
- Rodrigo Gobbo GarciaRGRodrigo Gobbo Garcia
- Priscila Mina FalsarellaPFPriscila Mina Falsarella
- Bruno Pagnin SchmidBSBruno Pagnin Schmid
- Daniel Tavares MalheirosDMDaniel Tavares Malheiros
- Ronaldo Hueb BaroniRBRonaldo Hueb Baroni
- Ary SerpaASAry Serpa
Open Access
- 25 September 2024
- journal article
- research article
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 22, eGS0683
Abstract
In Brief Mariotti et al. demonstrated that radiofrequency ablation is more cost-effective, achieves a higher complete response rate, and has a lower complication rate than percutaneous ethanol injection in patients with early-stage hepatocellular carcinoma. Highlights Radiofrequency ablation and percutaneous ethanol injection are neoadjuvant hepatocellular carcinoma treatment methods. Radiofrequency ablation achieves a higher complete response rate (96.3% versus 60.0%, p=0.001). Total cost analyses showed radiofrequency ablation as a more expensive method (p<0.001). The incremental cost-effectiveness ratio was US$ -2674.59 withKeywords
This publication has 14 references indexed in Scilit:
- Epidemiology of Hepatocellular CarcinomaHepatology, 2020
- Impact of successful local ablative bridging therapy prior to liver transplantation on long-term survival in patients with hepatocellular carcinoma in cirrhosisJournal of Cancer Research and Clinical Oncology, 2020
- mRECIST for HCC: Performance and novel refinementsJournal of Hepatology, 2020
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinomaJournal of Hepatology, 2018
- Radiofrequency vs Microwave Ablation After Neoadjuvant Transarterial Bland and Drug-Eluting Microsphere Chembolization for the Treatment of Hepatocellular CarcinomaCurrent Problems in Diagnostic Radiology, 2017
- Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinomaBritish Journal of Surgery, 2017
- Proposal of a New Adverse Event Classification by the Society of Interventional Radiology Standards of Practice CommitteeJournal of Vascular and Interventional Radiology, 2017
- Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variableStatistical Methods in Medical Research, 2015
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS) StatementValue in Health, 2013
- Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: A randomized controlled trialScandinavian Journal of Gastroenterology, 2008